phenylpiperazine has been researched along with piperidines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| el-Ashmawy, MB; Fischer, JB; Glennon, RA; Herndon, JL; Howie, KJ; Ismaiel, AM; Server, AC; Yousif, MY | 1 |
| Barrett, JE; Brady, LS | 1 |
| Kumar, R; Singh, P | 1 |
| Alvaro, G; Cimarosti, Z; Corsi, M; Di Fabio, R; Donati, D; Gerrard, PA; Griffante, C; Guercio, G; Marchioro, C; Mattioli, M; Melotto, S; Montanari, D; Pentassuglia, G; Pizzi, DA; Provera, S; Ratti, E; Rossi, T; Trist, DG; Zonzini, L | 1 |
| Pettersson, F; Pontén, H; Sonesson, C; Waters, N; Waters, S | 1 |
| Ashok, P; Balana-Fouce, R; Carbajo-Andres, R; Chander, S; Gowri Chandra Sekhar, KV; Perez-Pertejo, MY; Reguera, RM; Sankaranarayanan, M | 1 |
6 other study(ies) available for phenylpiperazine and piperidines
| Article | Year |
|---|---|
Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity sigma ligands.
Topics: Animals; Guinea Pigs; In Vitro Techniques; Ligands; Piperazines; Piperidines; Radioligand Assay; Receptors, Dopamine; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, sigma; Structure-Activity Relationship | 1991 |
Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys.
Topics: 5-Hydroxytryptophan; Animals; Cinanserin; Conditioning, Operant; Cyproheptadine; Electroshock; Female; Ketanserin; Male; Metergoline; Methysergide; Piperazines; Piperidines; Pyrazines; Quipazine; Receptors, Serotonin; Saimiri | 1985 |
Quantitative structure-activity relationship study of novel alpha1a-selective adrenoceptor antagonists.
Topics: Adrenergic Agonists; Adrenergic alpha-1 Receptor Antagonists; Binding Sites; Humans; Male; Piperazines; Piperidines; Prostatic Hyperplasia; Pyrimidinones; Quantitative Structure-Activity Relationship | 2001 |
Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
Topics: Administration, Oral; Animals; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Drug Evaluation, Preclinical; Fluorobenzenes; Gerbillinae; Neurokinin-1 Receptor Antagonists; Pharmacokinetics; Piperazines; Piperidines; Structure-Activity Relationship | 2009 |
Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Cell Line; Corpus Striatum; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Humans; Ligands; Male; Models, Chemical; Molecular Structure; Motor Activity; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2010 |
Synthesis and activity of benzopiperidine, benzopyridine and phenyl piperazine based compounds against Leishmania infantum.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Chromatography, Thin Layer; Inhibitory Concentration 50; Leishmania infantum; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Piperazines; Piperidines; Pyridines; Quinolines; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Near-Infrared; Spleen; Tetrahydroisoquinolines | 2018 |